These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8298358)

  • 21. [Decisions regarding cholesterol-lowering therapy in the elderly: the experience in a lipid clinic and a review of the literature].
    Garrido Sanjuán JA; Pía Iglesias G; González Moraleja J; Sesma P
    An Med Interna; 1998 Jun; 15(6):305-10. PubMed ID: 9656510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Do beta blockers affect hypercholesterolemia treatment?].
    Richter WO; Ritter MM
    Med Monatsschr Pharm; 1991 Jan; 14(1):23-4. PubMed ID: 1673218
    [No Abstract]   [Full Text] [Related]  

  • 23. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
    Elliott WJ
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):409-11. PubMed ID: 8722446
    [No Abstract]   [Full Text] [Related]  

  • 24. [Profitability of hypolipidemic drug treatment].
    Gérvas J; Pérez Fernández M
    Med Clin (Barc); 1996 Jun; 107(1):37-8. PubMed ID: 8709674
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands.
    Mantel-Teeuwisse AK; Verschuren WM; Klungel OH; de Boer A; Kromhout D
    Br J Clin Pharmacol; 2004 Sep; 58(3):310-6. PubMed ID: 15327591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Farmacotherapeutisch Kompas 1990-1991].
    Ottervanger JP
    Ned Tijdschr Geneeskd; 1991 Jan; 135(4):150. PubMed ID: 2002860
    [No Abstract]   [Full Text] [Related]  

  • 27. [Which antilipemic agent when?].
    Schwandt P
    Internist (Berl); 1989 Sep; 30(9):625. PubMed ID: 2807786
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current cellular aspects of atherosclerosis. Risk factors in its etiology and treatment].
    Schettler G
    Wien Med Wochenschr; 1990; 140(21):530-1. PubMed ID: 2275208
    [No Abstract]   [Full Text] [Related]  

  • 29. Current world literature.
    Curr Opin Lipidol; 2009 Dec; 20(6):512-9. PubMed ID: 19935200
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treadmill testing and selection of hypercholesterolemic patients for treatment.
    Vine DL
    Kans Med; 1989 Nov; 90(11):323-4. PubMed ID: 2687549
    [No Abstract]   [Full Text] [Related]  

  • 32. Treating hypercholesterolemia and hypertension based on lifetime global risk.
    Kostis JB
    Am J Cardiol; 2007 Jul; 100(1):138-42. PubMed ID: 17599456
    [No Abstract]   [Full Text] [Related]  

  • 33. [Secondary prevention of coronary heart disease with lipid lowering drugs. Evaluating outcome eliminates the controversy].
    Pedersen TR
    Internist (Berl); 1995 Dec; 36(12):1174-8. PubMed ID: 8567223
    [No Abstract]   [Full Text] [Related]  

  • 34. [Should lipid-lowering drugs be administered to normolipemic or mild hyperlipemic patients with coronary risk factors? Arguments for].
    de Teresa Galván E; Jiménez Navarro M
    Rev Esp Cardiol; 1996 Jul; 49(7):483-5. PubMed ID: 8754441
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of dyslipidemia.
    Akel MM; Salti I
    J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug treatment of hypercholesterolaemia. Establish diagnosis before treatment.
    Feher MD; Wierzbicki AS; Reynolds TM
    BMJ; 1994 Jan; 308(6920):56-7. PubMed ID: 8298359
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypercholesterolemia. The NCEP Adult Treatment Panel III Guidelines.
    Morgan JM; Capuzzi DM
    Geriatrics; 2003 Aug; 58(8):33-8; quiz 41. PubMed ID: 12938250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of cholesterol in coronary heart disease risk reduction.
    Woodhead GA
    Nurse Pract; 1996 Sep; 21(9):45, 48, 51-3. PubMed ID: 8884794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive lipid-lowering therapy: obvious benefits, possible risks.
    Zimlichman E; Szyper-Kravitz M; Katz U; Shoenfeld Y
    Isr Med Assoc J; 2006 Dec; 8(12):890-1. PubMed ID: 17214117
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of mushroom (Pleurotus florida) as hypocholesterolemic/hypolipidemic agent.
    Khanna PK; Bhandari R; Soni GL; Singh CK; Garcha HS; Mittar D
    Indian J Exp Biol; 1993 Jun; 31(6):567-8. PubMed ID: 8406606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.